Scully Royalty Ltd (NYSE: SRL) stock closed at $4.53 on 11/2/23 after a major increase of 14.1%. The stock has been weak relative to the market over the last nine months but has risen 10.5% […]
Intevac Inc (NASDAQ: IVAC) stock closed at $3.48 on 11/2/23 after a major increase of 11.5%. The stock has been extremely weak relative to the market over the last nine months but has risen 9.4% […]
On 11/2/23, Pediatrix Medical Group Inc (NYSE: MD) stock suffered a major decline of -11.8%, closing at $9.89. Relative to the market the stock has been weak over the last nine months and has declined […]
ACI Worldwide Inc (NASDAQ: ACIW) stock enjoyed a major increase of 13.8% on 11/2/23. The shares closed at $23.03. The stock has been weak relative to the market over the last nine months but has […]
BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) has reported a loss for its third fiscal quarter (ending September 30) of $-0.19 versus a loss $-0.23 for the same period a year ago. This result was in line […]
For its third fiscal quarter (ending September 30), Innodata Inc (NASDAQ: INOD) has reported E.P.S. of $0.01 compared to $-0.12 a year ago. E.P.S. were $-0.16 for the latest four quarters through September 30 versus […]
Rocky Brands Inc (NASDAQ: RCKY) stock enjoyed a major increase of 43.7% on 11/2/23. The shares closed at $18.11. The stock has been extremely weak relative to the market over the last nine months but […]
American Superconductor Corp (NASDAQ: AMSC) stock enjoyed a major increase of 13.4% on 11/2/23. The shares closed at $7.26. The stock has been exceptionally strong relative to the market over the last nine months and […]
Stryker Corp (NYSE: SYK) has reported E.P.S. of $1.82 for its third fiscal quarter (ending September 30) versus $2.16 for the same period a year ago — a decline of -16%. Relative to the consensus […]
Standex International Corp (NYSE: SXI) has reported E.P.S. of $1.61 for its first fiscal quarter (ending September 30) versus $1.55 for the same period a year ago — an increase of 4%. Relative to the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research